620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates

• Brian Jones,
• Pamela Shaw,
• Naniye Malli Cetinbas,
• Travis Monnell,
• Winnie Lee,
• Kalli Catcott,
• Chen-Ni Chin,
• Kelly Slocum,
• LiuLiang Qin,
• Kenneth Avocetien,
• Keith Bentley,
• Susan Clardy,
• Eugene Kelleher,
• Joshua Thomas,
• Rebecca Mosher,
• Dorin Toader,
• Jeremy Duvall,
• Raghida Bukhalid,
• Marc Damelin,
• Timothy Lowinger

Affiliations

Brian Jones

Mersana Therapeutics, Cambridge, MA, USA

Pamela Shaw

Mersana Therapeutics, Cambridge, MA, USA

Naniye Malli Cetinbas

Mersana Therapeutics, Cambridge, MA, USA

Travis Monnell

Mersana Therapeutics, Cambridge, MA, USA

Winnie Lee

Mersana Therapeutics, Cambridge, MA, USA

Kalli Catcott

Mersana Therapeutics, Cambridge, MA, USA

Chen-Ni Chin

Mersana Therapeutics, Cambridge, MA, USA

Kelly Slocum

Mersana Therapeutics, Cambridge, MA, USA

LiuLiang Qin

Mersana Therapeutics, Cambridge, MA, USA

Kenneth Avocetien

Mersana Therapeutics, Cambridge, MA, USA

Keith Bentley

Mersana Therapeutics, Cambridge, MA, USA

Susan Clardy

Mersana Therapeutics, Cambridge, MA, USA

Eugene Kelleher

Mersana Therapeutics, Cambridge, MA, USA

Joshua Thomas

Mersana Therapeutics, Cambridge, MA, USA

Rebecca Mosher

Mersana Therapeutics, Cambridge, MA, USA

Dorin Toader

Mersana Therapeutics, Cambridge, MA, USA

Jeremy Duvall

Mersana Therapeutics, Cambridge, MA, USA

Raghida Bukhalid

Mersana Therapeutics, Cambridge, MA, USA

Marc Damelin

Mersana Therapeutics, Cambridge, MA, USA

Timothy Lowinger

Mersana Therapeutics, Cambridge, MA, USA